Page last updated: 2024-09-03

ro 8-0576 and 1-methyl-4-phenylpyridinium

ro 8-0576 has been researched along with 1-methyl-4-phenylpyridinium in 1 studies

Compound Research Comparison

Studies (ro 8-0576)	Trials (ro 8-0576)	Recent Studies (post-2010) (ro 8-0576)	Studies (1-methyl-4-phenylpyridinium)	Trials (1-methyl-4-phenylpyridinium)	Recent Studies (post-2010) (1-methyl-4-phenylpyridinium)
214	63	67	1,854	1	593

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Himori, N; Mishima, K	1

Other Studies

1 other study(ies) available for ro 8-0576 and 1-methyl-4-phenylpyridinium

Article	Year
The COMT inhibitor tolcapone potentiates the anticataleptic effect of Madopar in MPP(+)-lesioned mice. Experientia, 1994, Oct-15, Volume: 50, Issue:10 Topics: 1-Methyl-4-phenylpyridinium; Animals; Benserazide; Benzophenones; Catalepsy; Catechol O-Methyltransferase Inhibitors; Drug Combinations; Drug Synergism; Haloperidol; Kinetics; Levodopa; Male; Mice; Mice, Inbred C57BL; Nitrophenols; Tolcapone; Tyrosine	1994

Article

Year

The COMT inhibitor tolcapone potentiates the anticataleptic effect of Madopar in MPP(+)-lesioned mice.

Experientia, 1994, Oct-15, Volume: 50, Issue:10

Topics: 1-Methyl-4-phenylpyridinium; Animals; Benserazide; Benzophenones; Catalepsy; Catechol O-Methyltransferase Inhibitors; Drug Combinations; Drug Synergism; Haloperidol; Kinetics; Levodopa; Male; Mice; Mice, Inbred C57BL; Nitrophenols; Tolcapone; Tyrosine

1994